Demographics (1)
- GENDER - Gender of participant (phv00290029.v1.p1)
Disease Events (1)
- AFFECTION_STATUS - Case control status of the subject for premenstrual dysphoric disorder (phv00290027.v1.p1)
Race and Ethnicity (1)
- RACE - Race of participant (phv00290028.v1.p1)
Other (15)
- ANALYTE_TYPE - Analyte Type (phv00290032.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00290031.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00290018.v1.p1)
- SAMPLE_ID - Sample ID (phv00290022.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00290030.v1.p1)
- SAMPLE_SOURCE - Source repository where samples originate (phv00290023.v1.p1)
- SAMPLE_USE - Sample Use (phv00290025.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00290033.v1.p1)
- SOURCE_SAMPLE_ID - Sample ID used in the Source Repository (phv00290024.v1.p1)
- SOURCE_SUBJECT_ID - Subject ID used in the Source Repository (phv00290020.v1.p1)
- SUBJECT_ID - Subject ID (phv00290021.v1.p1)
- SUBJECT_ID - Subject ID (phv00290017.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00290026.v1.p1)
- SUBJECT_SOURCE - Source repository where subjects originate (phv00290019.v1.p1)
- TREATMENT - Treatments to the cell lines (phv00290034.v1.p1)